Elevated level of neuroserpin is an indication for the resistance to gambogic acid-induced apoptosis and oxidative stress in triple-negative breast cancer cells
This work is licensed under the Creative Commons Attribution 4.0 International License.
Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci. 2017; 151:1–32.WintersSMartinCMurphyDShokarNKBreast cancer epidemiology, prevention, and screeningProg Mol Biol Transl Sci2017151132Search in Google Scholar
World Health Organization. Projections of mortality and causes of death, 2015 and 2030. 2020.World Health OrganizationProjections of mortality and causes of death, 2015 and 20302020Search in Google Scholar
Karami Fath M, Azargoonjahromi A, Kiani A, Jalalifar F, Osati P, Akbari Oryani M, et al. The role of epigenetic modifications in drug resistance and treatment of breast cancer. Cell Mol Biol Lett. 2022; 27:52. doi: 10.1186/s11658-022-00344-6Karami FathMAzargoonjahromiAKianiAJalalifarFOsatiPAkbari OryaniMThe role of epigenetic modifications in drug resistance and treatment of breast cancerCell Mol Biol Lett2022275210.1186/s11658-022-00344-6Open DOISearch in Google Scholar
Wilson TR, Johnston PG, Longley DB. Anti-apoptotic mechanisms of drug resistance in cancer. Curr Cancer Drug Targets. 2009; 9:307–19.WilsonTRJohnstonPGLongleyDBAnti-apoptotic mechanisms of drug resistance in cancerCurr Cancer Drug Targets2009930719Search in Google Scholar
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117:927–39.YangJManiSADonaherJLRamaswamySItzyksonRAComeCTwist, a master regulator of morphogenesis, plays an essential role in tumor metastasisCell200411792739Search in Google Scholar
Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, Shi B. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res. 2015; 5:2929–43.DaiXLiTBaiZYangYLiuXZhanJShiBBreast cancer intrinsic subtype classification, clinical use and future trendsAm J Cancer Res20155292943Search in Google Scholar
Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007; 13:4429–34.DentRTrudeauMPritchardKIHannaWMKahnHKSawkaCATriple-negative breast cancer: clinical features and patterns of recurrenceClin Cancer Res200713442934Search in Google Scholar
Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019; 321:288–300.WaksAGWinerEPBreast cancer treatment: a reviewJAMA2019321288300Search in Google Scholar
Hanikoglu A, Kucuksayan E, Hanikoglu F, Ozben T, Menounou G, Sansone A, et al. Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes. Can J Physiol Pharmacol. 2020; 98:131–8.HanikogluAKucuksayanEHanikogluFOzbenTMenounouGSansoneAEffects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranesCan J Physiol Pharmacol2020981318Search in Google Scholar
Hanikoglu A, Kucuksayan E, Hanikoglu F, Ozben T, Menounou G, Sansone A, et al. Effects of somatostatin and vitamin C on the fatty acid profile of breast cancer cell membranes. Anticancer Agents Med Chem. 2019; 19:1899–909.HanikogluAKucuksayanEHanikogluFOzbenTMenounouGSansoneAEffects of somatostatin and vitamin C on the fatty acid profile of breast cancer cell membranesAnticancer Agents Med Chem2019191899909Search in Google Scholar
Aung TN, Qu Z, Kortschak RD, Adelson DL. Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci. 2017; 18. 656. doi: 10.3390/ijms18030656AungTNQuZKortschakRDAdelsonDLUnderstanding the effectiveness of natural compound mixtures in cancer through their molecular mode of actionInt J Mol Sci20171865610.3390/ijms18030656Open DOISearch in Google Scholar
Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020; 177:1409–23.LinSRChangCHHsuCFTsaiMJChengHLeongMKNatural compounds as potential adjuvants to cancer therapy: preclinical evidenceBr J Pharmacol2020177140923Search in Google Scholar
Wang QL, Yang DZ, Lv C. Antiinflammatory effects of gambogic acid in murine collageninduced arthritis through PI3K/Akt signaling pathway. Mol Med Rep. 2018; 17:4791–6.WangQLYangDZLvCAntiinflammatory effects of gambogic acid in murine collageninduced arthritis through PI3K/Akt signaling pathwayMol Med Rep20181747916Search in Google Scholar
Pandey MK, Karelia D, Amin SG. Gambogic acid and its role in chronic diseases. Adv Exp Med Biol. 2016; 928:375–95.PandeyMKKareliaDAminSGGambogic acid and its role in chronic diseasesAdv Exp Med Biol201692837595Search in Google Scholar
Pan H, Jansson KH, Beshiri ML, Yin J, Fang L, Agarwal S, et al. Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer. Oncotarget. 2017; 8:77181–94.PanHJanssonKHBeshiriMLYinJFangLAgarwalSGambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerOncotarget201787718194Search in Google Scholar
Zhang L, Yi Y, Chen J, Sun Y, Guo Q, Zheng Z, Song S. Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells. Biochem Biophys Res Commun. 2010; 403:282–7.ZhangLYiYChenJSunYGuoQZhengZSongSGambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cellsBiochem Biophys Res Commun20104032827Search in Google Scholar
Tang Q, Lu M, Zhou H, Chen D, Liu L. Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity. Oncol Lett. 2017; 13:384–8.TangQLuMZhouHChenDLiuLGambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activityOncol Lett2017133848Search in Google Scholar
Wang X, Chen W. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer Agents Med Chem. 2012; 12:994–1000.WangXChenWGambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasisAnticancer Agents Med Chem2012129941000Search in Google Scholar
Kucuksayan E, Sircan-Kucuksayan A. Real-time detection of doxorubicin-induced apoptosis in breast cancer cells using the back reflection spectroscopy. East J Med. 2021; 26:128–34.KucuksayanESircan-KucuksayanAReal-time detection of doxorubicin-induced apoptosis in breast cancer cells using the back reflection spectroscopyEast J Med20212612834Search in Google Scholar
Kucuksayan E, Cort A, Timur M, Ozdemir E, Yucel SG, Ozben T. N-acetyl-L-cysteine inhibits bleomycin induced apoptosis in malignant testicular germ cell tumors. J Cell Biochem. 2013; 114:1685–94.KucuksayanECortATimurMOzdemirEYucelSGOzbenTN-acetyl-L-cysteine inhibits bleomycin induced apoptosis in malignant testicular germ cell tumorsJ Cell Biochem2013114168594Search in Google Scholar
Betriu N, Semino CE. Development of a 3D co-culture system as a cancer model using a self-assembling peptide scaffold. Gels. 2018; 4:65. doi: 10.3390/gels4030065BetriuNSeminoCEDevelopment of a 3D co-culture system as a cancer model using a self-assembling peptide scaffoldGels201846510.3390/gels4030065Open DOISearch in Google Scholar
Wankun X, Wenzhen Y, Min Z, Weiyan Z, Huan C, Wei D, et al. Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro. Mol Vis. 2011; 17:3512–22.WankunXWenzhenYMinZWeiyanZHuanCWeiDProtective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitroMol Vis201117351222Search in Google Scholar
Kntayya S, Ibrahim M, Mohd Ain N, Iori R, Ioannides C, Abdull Razis A. Induction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 Cells. Nutrients. 2018; 10:718. doi: 10.3390/nu10060718KntayyaSIbrahimMMohd AinNIoriRIoannidesCAbdull RazisAInduction of apoptosis and cytotoxicity by isothiocyanate sulforaphene in human hepatocarcinoma HepG2 CellsNutrients20181071810.3390/nu10060718Open DOISearch in Google Scholar
Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci U S A. 2020; 117:5931–7.NaTYSchectersonLMendonsaAMGumbinerBMThe functional activity of E-cadherin controls tumor cell metastasis at multiple stepsProc Natl Acad Sci U S A202011759317Search in Google Scholar
Nguyen PT, Nguyen D, Chea C, Miyauchi M, Fujii M, Takata T. Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer. Oncotarget. 2018; 9: 31516–30.NguyenPTNguyenDCheaCMiyauchiMFujiiMTakataTInteraction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancerOncotarget201893151630Search in Google Scholar
Zhao L, Guo QL, You QD, Wu ZQ, Gu HY. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull. 2004; 27:998–1003.ZhaoLGuoQLYouQDWuZQGuHYGambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cellsBiol Pharm Bull2004279981003Search in Google Scholar
Chang WS, Chang NT, Lin SC, Wu CW, Wu FY. Tissue-specific cancer-related serpin gene cluster at human chromosome band 3q26. Genes Chromosomes Cancer. 2000; 29:240–55.ChangWSChangNTLinSCWuCWWuFYTissue-specific cancer-related serpin gene cluster at human chromosome band 3q26Genes Chromosomes Cancer20002924055Search in Google Scholar
Hasumi H, Ishiguro H, Nakamura M, Sugiura S, Osada Y, Miyoshi Y, et al. Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival. Int J Cancer. 2005; 115:911–6.HasumiHIshiguroHNakamuraMSugiuraSOsadaYMiyoshiYNeuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survivalInt J Cancer20051159116Search in Google Scholar
Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 2014; 156:1002–16.ValienteMObenaufACJinXChenQZhangXHLeeDJSerpins promote cancer cell survival and vascular co-option in brain metastasisCell2014156100216Search in Google Scholar
Wang S, Wang L, Chen M, Wang Y. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Chem Biol Interact. 2015; 235:76–84.WangSWangLChenMWangYGambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expressionChem Biol Interact20152357684Search in Google Scholar
Shergill K, Sen A, Pillai HJ. Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg. 2018; 44:182–90.ShergillKSenAPillaiHJRole of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinomaJ Korean Assoc Oral Maxillofac Surg20184418290Search in Google Scholar
Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol. 1999; 147:631–44.NiemanMTPrudoffRSJohnsonKRWheelockMJN-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expressionJ Cell Biol199914763144Search in Google Scholar
Zhao K, Zhang S, Song X, Yao Y, Zhou Y, You Q, et al. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFbeta1-induced epithelial-to-mesenchymal transition. Oncotarget. 2017; 8:27120–36.ZhaoKZhangSSongXYaoYZhouYYouQGambogic acid suppresses cancer invasion and migration by inhibiting TGFbeta1-induced epithelial-to-mesenchymal transitionOncotarget201782712036Search in Google Scholar
Li CY, Wang Q, Wang XM, Li GX, Shen S, Wei XL. Gambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathways. Eur J Pharmacol. 2019; 864:172719. doi: 10.1016/j.ejphar.2019.172719LiCYWangQWangXMLiGXShenSWeiXLGambogic acid exhibits anti-metastatic activity on malignant melanoma mainly through inhibition of PI3K/Akt and ERK signaling pathwaysEur J Pharmacol201986417271910.1016/j.ejphar.2019.172719Open DOISearch in Google Scholar
Liu Z, Ding Y, Ye N, Wild C, Chen H, Zhou J. Direct activation of Bax protein for cancer therapy. Med Res Rev. 2016; 36: 313–41.LiuZDingYYeNWildCChenHZhouJDirect activation of Bax protein for cancer therapyMed Res Rev20163631341Search in Google Scholar
Cetin A, Ozgur A, Kuzucu M, Çankaya M. Investigation of the synergistic effects of trastuzumab and gambogic acid in Her-2 positive breast cancer cell line. Hacettepe J Biol Chem. 2020; 48:291–9.CetinAOzgurAKuzucuMÇankayaMInvestigation of the synergistic effects of trastuzumab and gambogic acid in Her-2 positive breast cancer cell lineHacettepe J Biol Chem2020482919Search in Google Scholar
Duan D, Zhang B, Yao J, Liu Y, Sun J, Ge C, Peng S, Fang J. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase. Free Radic Biol Med. 2014; 69:15–25.DuanDZhangBYaoJLiuYSunJGeCPengSFangJGambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductaseFree Radic Biol Med2014691525Search in Google Scholar
Cheng Y, Loh YP, Birch NP. Neuroserpin attenuates H(2)O(2)-induced oxidative stress in hippocampal neurons via AKT and BCL-2 signaling pathways. J Mol Neurosci. 2017; 61:123–31.ChengYLohYPBirchNPNeuroserpin attenuates H(2)O(2)-induced oxidative stress in hippocampal neurons via AKT and BCL-2 signaling pathwaysJ Mol Neurosci20176112331Search in Google Scholar
Kaufmann T, Strasser A, Jost PJ. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ. 2012; 19:42–50.KaufmannTStrasserAJostPJFas death receptor signalling: roles of Bid and XIAPCell Death Differ2012194250Search in Google Scholar
Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, et al. Antioxidants for the treatment of breast cancer: are we there yet? Antioxidants. 2021; 10:205. doi: 10.3390/antiox10020205Griñan-LisonCBlaya-CánovasJLLópez-TejadaAÁvalos-MorenoMNavarro-OcónACaraFEAntioxidants for the treatment of breast cancer: are we there yet?Antioxidants20211020510.3390/antiox10020205Open DOISearch in Google Scholar
Rodriguez-Gonzalez R, Sobrino T, Rodriguez-Yanez M, Millan M, Brea D, Miranda E, et al. Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke. J Transl Med. 2011; 9:58. doi: 10.1186/1479-5876-9-58Rodriguez-GonzalezRSobrinoTRodriguez-YanezMMillanMBreaDMirandaEAssociation between neuroserpin and molecular markers of brain damage in patients with acute ischemic strokeJ Transl Med201195810.1186/1479-5876-9-58Open DOISearch in Google Scholar
Gupta V, Mirzaei M, Gupta VB, Chitranshi N, Dheer Y, Vander Wall R, et al. Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin. Sci Rep. 2017; 7:8412. doi: 10.1038/s41598-017-08688-2GuptaVMirzaeiMGuptaVBChitranshiNDheerYVander WallRGlaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpinSci Rep20177841210.1038/s41598-017-08688-2Open DOISearch in Google Scholar
Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res. 2007; 13: 1133–9.JiaHLYeQHQinLXBudhuAForguesMChenYGene expression profiling reveals potential biomarkers of human hepatocellular carcinomaClin Cancer Res20071311339Search in Google Scholar